Z-1748-2025 Class II Ongoing

Recalled by Abbott Molecular, Inc. — Des Plaines, IL

FDA device recall Z-1748-2025 was initiated by Abbott Molecular, Inc. on Apr 28, 2025 and is designated Class II. Reason for recall: There were reports of an increase in reactive negative controls and false positive results. The recall status is ongoing. Affected quantity: 1447 units.

Recall details

Product Type
Devices
Report Date
May 21, 2025
Initiation Date
Apr 28, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1447 units

Product description

Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the qualitative detection and differentiation of RNA from influenza A virus (flu A), influenza B virus (flu B), Respiratory Syncytial Virus (RSV), and SARS-CoV-2 in nasopharyngeal (NP) swab specimens collected by a healthcare provider, from individuals with signs and symptoms of respiratory tract infection

Reason for recall

There were reports of an increase in reactive negative controls and false positive results.

Distribution pattern

Worldwide - US Nationwide distribution.

Code information

UDI-DI: 00884999049338; Lot Numbers: 409383 410627 411921

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1748-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1748-2025. Report a data issue: hello@regdatalab.com.